All references with links to [Free Full-text] are freely available online to users in the UK. Links to PubMed abstracts are also provided where available. CKS is not responsible for the content of external sites.

Free Full-text links are to dynamic documents that may have been updated since they were originally cited in the CKS topic. All links are checked regularly by CKS Information Specialists and updated to the latest version. Changes in the content of updated documents will not be reflected in the CKS topic text until the next revision.

The following references were cited in November 2007. References dated after this reflect new evidence incorporated since original publication of this topic.

1. ABPI Medicines Compendium (2003) Summary of product characteristics for Depo-Medrone 40mg/ml. Electronic Medicines Compendium. Datapharm Communication Ltd. www.emc.medicines.org.uk [Free Full-text]
2. ABPI Medicines Compendium (2004) Colchicine tablets BP 0.5mg. Electronic Medicines Compendium. Datapharm Communications Ltd. www.emc.medicines.org.uk [Free Full-text]
3. ABPI Medicines Compendium (2006) Summary of product characteristics for Zyloric tablets 100mg, 300mg. Electronic Medicines Compendium. Datapharm Communications Ltd. www.emc.medicines.org.uk [Free Full-text]
4. ABPI Medicines Compendium (2007a) Summary of product characteristics for Kenalog intra-articular / intramuscular injection. Electronic Medicines Compendium. Datapharm Communications Ltd. www.emc.medicines.org.uk [Free Full-text]
5. ABPI Medicines Compendium (2007b) Summary of product characteristics for Naprosyn 250mg and 500mg tablets. Electronic Medicines Compendium. Datapharm Communications Ltd. www.emc.medicines.org.uk [Free Full-text]
6. ABPI Medicines Compendium (2007c) Summary of product characteristics for Voltarol tablets. Electronic Medicines Compendium. Datapharm Communication Ltd. www.emc.medicines.org.uk [Free Full-text]
7. ABPI Medicines Compendium (2010) Summary of product characteristics for Adenuric film-coated tablets. Electronic Medicines Compendium. Datapharm Communications Ltd. www.emc.medicines.org.uk [Free Full-text]
8. Ahern, M.J., Reid, C., Gordon, T.P. et al. (1987) Does colchicine work? The results of the first controlled study in acute gout. Australian & New Zealand Journal of Medicine 17(3), 301-304. [Abstract]
9. Aldington, S., Shirtcliffe, P., Weatherall, M. and Beasley, R. (2005) Systematic review and meta-analysis of the risk of major cardiovascular events with etoricoxib therapy. New Zealand Medical Journal 118(1223), U1684. [Abstract] [Free Full-text]
10. Alloway, J.A., Moriarty, M.J., Hoogland, Y.T. and Nashel, D.J. (1993) Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis. Journal of Rheumatology 20(1), 111-113. [Abstract]
11. Bencardino, J.T. and Hassankhani, A. (2003) Calcium pyrophosphate dihydrate crystal deposition disease. Seminars in Musculoskeletal Radiology 7(3), 175-185. [Abstract]
12. Beutler, A.M., Rull, M., Schlesinger, N. et al. (2001) Treatment with allopurinol decreases the number of acute gout attacks despite persistently elevated serum uric acid levels. Clinical & Experimental Rheumatology 19(5), 595.
13. BNF 53 (2007) British National Formulary. 53rd edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain.
14. Bomalaski, J.S., Lluberas, G. and Schumacher, H.R., Jr. (1986) Monosodium urate crystals in the knee joints of patients with asymptomatic nontophaceous gout. Arthritis & Rheumatism 29(12), 1480-1484. [Abstract]
15. Borstad, G.C., Bryant, L.R., Abel, M.P. et al. (2004) Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis. Journal of Rheumatology 31(12), 2429-2432. [Abstract]
16. Bull, P.W. and Scott, J.T (1989) Intermittent control of hyperuricemia in the treatment of gout. Journal of Rheumatology 16(9), 1246-1248. [Abstract]
17. Campion, E.W., Glynn, R.J. and DeLabry, L.O. (1987) Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study. American Journal of Medicine 82(3), 421-426. [Abstract]
18. Caspi, D., Lubart, E., Graff, E. et al. (2000) The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis & Rheumatism 43(1), 103-108. [Abstract] [Free Full-text]
19. Choi, H.K. (2005) Dietary risk factors for rheumatic diseases. Current Opinion in Rheumatology 17(2), 141-146. [Abstract]
20. Choi, H.K., Atkinson, K., Karlson, E.W. et al. (2004a) Alcohol intake and risk of incident gout in men: a prospective study. Lancet 363(9417), 1277-1281. [Abstract]
21. Choi, H.K., Atkinson, K., Karlson, E.W. et al. (2004b) Purine-rich foods, dairy and protein intake, and the risk of gout in men. New England Journal of Medicine 350(11), 1093-1103. [Abstract] [Free Full-text]
22. Choi, H.K., Atkinson, K., Karlson, E.W. and Curhan, G. (2005a) Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Archives of Internal Medicine 165(7), 742-748. [Abstract] [Free Full-text]
23. Choi, H.K., Mount, D.B. and Reginato, A.M. (2005b) Pathogenesis of gout. Annals of Internal Medicine 143(7), 499-516. [Free Full-text]
24. Cohen, M.G. and Emmerson, B.T. (1998) Gout. In: Klippel, J.H., Dieppe, P. and Arnett, F.C. (Eds.) Rheumatology. 2nd edn. London: St Louis, Mosby. Chapter 14. 14.1-14.14.
25. CSM (2002) Non-steroidal anti-inflammatory drugs (NSAIDs) and gastrointestinal (GI) safety. Current Problems in Pharmacovigilance 28(Apr), 5. [Free Full-text]
26. Delbarre, F., Amor, B., Auscher, C. and de Gery, A. (1966) Treatment of gout with allopurinol. A study of 106 cases. Annals of the Rheumatic Diseases 25(6), 627-633. [Free Full-text]
27. Dessein, P.H., Shipton, E.A., Stanwix, A.E. et al. (2000) Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Annals of the Rheumatic Diseases 59(7), 539-543. [Abstract] [Free Full-text]
28. Dutch College of General Practitioners (2004) NHG practice guideline 'gout'. Dutch College of General Practitioners. http://nhg.artsennet.nl
29. DynaMed (2007) Gout. Dynamed. EBSCO Publishing. www.dynamicmedical.com
30. Fernandez, C., Noguera, R., Gonzalez, J.A. and Pascual, E. (1999) Treatment of acute attacks of gout with a small dose of intraarticular triamcinolone acetonide. Journal of Rheumatology 26(10), 2285-2286.
31. Garcia de la Torre, I. (1987) Estudio doble-ciego paralelo, comparativo con tenoxicam vs placebo en artritis gotosa aguda [Spanish, double-blind parallel study comparing tenoxicam and placebo in acute gouty arthritis]. Investigacion Medica Internacional 14(2), 92-97.
32. Gibson, T. (2005) Successful management of acute and chronic gout. ePrescriber. www.escriber.com
33. Gray, R.G, Tenenbaum, J. and Gottlieb, N.L. (1981) Local corticosteroid injection treatment in rheumatic disorders. Seminars in Arthritis & Rheumatism 10(4), 231-254.
34. Groff, G.D., Franck, W.A. and Raddatz, D.A. (1990) Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Seminars in Arthritis & Rheumatism 19(6), 329-336. [Abstract]
35. Harris, M., Bryant, L.R., Danaher, P. and Alloway, J. (2000) Effect of low dose daily aspirin on serum urate levels and urinary excretion in patients receiving probenecid for gouty arthritis. Journal of Rheumatology 27(12), 2873-2876. [Abstract]
36. Jordan, K, M., Cameron, J.S., Snaith, M. et al. (2007) British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. British Society for Rheumatology. www.rheumatology.org.uk [Free Full-text]
37. Kim, K.Y., Ralph, Schumacher H., Hunsche, E. et al. (2003) A literature review of the epidemiology and treatment of acute gout. Clinical Therapeutics 25(6), 1593-1617. [Abstract]
38. Levinson, D.J. and Becker, M.A. (1993) Clinical gout and the pathogenesis of hyperuricemia. In: McCarty, D.J. and Koopman, W.J. (Eds.) Arthritis and allied conditions. 12th edn. Philadelphia: Lea and Febriger. 1773-1818.
39. Lin, K.C., Lin, H.Y. and Chou, P. (2000a) Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen. Journal of Rheumatology 27(4), 1045-1050. [Abstract]
40. Lin, K.C., Lin, H.Y. and Chou, P. (2000b) The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. Journal of Rheumatology 27(6), 1501-1505. [Abstract]
41. Li-Yu, J., Clayburne, G., Sieck, M. et al. (2001) Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? Journal of Rheumatology 28(3), 577-580. [Abstract]
42. Man, C.Y., Cheung, I.T., Cameron, P.A. and Rainer, T.H. (2007) Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial. Annals of Emergency Medicine 49(5), 670-677. [Abstract]
43. MHRA (2009) Colchicine: reminder on risk of serious and fatal toxicity in overdose. Drug Safety Update 3(4), 5. [Free Full-text]
44. Micromedex (2007) MICROMEDEX [CD-ROM]. (Vol 131, 1st quarter 2007). Thomson Healthcare.
45. Mikuls, T.R., Farrar, J.T., Bilker, W.B. et al. (2005) Gout epidemiology: results from the UK General Practice Research Database, 1990-1999. Annals of the Rheumatic Diseases 64(2), 267-272. [Abstract] [Free Full-text]
46. Morris, I., Varughese, G. and Mattingly, P. (2003) Colchicine in acute gout. British Medical Journal 327(7426), 1275-1276. [Free Full-text]
47. Naas, J.E. and Sanders, L.J. (1998) Chronic tophaceous gout in a patient with a history of allopurinol toxicity. Cutis 62(5), 239-241. [Abstract]
48. NICE (2008) Febuxostat for the management of hyperuricaemia in people with gout. Technology appraisal guidance 164. National Institute for Health and Clinical Excellence. www.nice.org.uk [Free Full-text]
49. Nicholls, A. and Scott, J.T. (1972) Effect of weight-loss on plasma and urinary levels of uric acid. Lancet 2(7789), 1223-1224.
50. Nuki, G. (2002) Gout. Medicine 30(9), 71-77.
51. O'Dell, J.R. (1983) Gout in Heberden's nodes. Arthritis & Rheumatism 26(11), 1413-1414.
52. Paulus, H.E., Schlosstein, L.H., Godfrey, R.G. et al. (1974) Prophylactic colchicine therapy of intercritical gout. A placebo-controlled study of probenecid-treated patients. Arthritis & Rheumatism 17(5), 609-614.
53. Perez-Ruiz, F., Atxotegi, J., Hernando, I. et al. (2006) Using serum urate levels to determine the period free of gouty symptoms after withdrawal of long-term urate-lowering therapy: a prospective study. Arthritis and Rheumatism 55(5), 786-790. [Abstract] [Free Full-text]
54. Rott, K.T. and Agudelo, C.A. (2003) Gout. Journal of the American Medical Association 289(21), 2857-2860.
55. Rubin, B.R., Burton, R., Navarra, S. et al. (2004) Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial. Arthritis & Rheumatism 50(2), 598-606. [Abstract] [Free Full-text]
56. Saag, K.G. and Choi, H. (2006) Epidemiology, risk factors, and lifestyle modifications for gout. Arthritis Research & Therapy 8(Suppl 1), S2. [Abstract] [Free Full-text]
57. Schlesinger, N. (2006) Response to application of ice may help differentiate between gouty arthritis and other inflammatory arthritides. Journal of Clinical Rheumatology 12(6), 275-276. [Abstract]
58. Schlesinger, N. and Schumacher, R. (2004) Gout. In: Tugwell, P., Shea, B., Boers, M. et al. (Eds.) Evidence-based rheumatology. London: BMJ Books. Chapter 5. 65-95.
59. Schlesinger, N., Detry, M.A., Holland, B.K. et al. (2002) Local ice therapy during bouts of acute gouty arthritis. Journal of Rheumatology 29(2), 331-334. [Abstract]
60. Schlesinger, N., Schumacher, R., Catton, M. and Maxwell, L. (2006a) Colchicine for acute gout (Cochrane Review). The Cochrane Library. Issue 4. John Wiley & Sons, Ltd. www.thecochranelibrary.com [Free Full-text]
61. Schlesinger, N., Moore, D.F., Sun, J.D. and Schumacher, H.R., J.r (2006b) A survey of current evaluation and treatment of gout. Journal of Rheumatology 33(10), 2050-2052. [Abstract]
62. Schumacher, H.R., Jr., Boice, J.A., Daikh, D.I. et al. (2002) Randomised double blind trial of etoricoxib and indometacin in threatment of acute gouty arthritis. British Medical Journal 324(7352), 1488-1492. [Abstract] [Free Full-text]
63. Scott, J.T. (1966) Comparison of allopurinol and probenecid. Annals of the Rheumatic Diseases 25(6), 623-626. [Free Full-text]
64. Stamp, L.K., O'Donnell, J.L. and Chapman, P.T. (2007) Emerging therapies in the long-term management of hyperuricaemia and gout. Internal Medicine Journal 37(4), 258-266. [Abstract]
65. Sutaria, S., Katbamna, R. and Underwood, M. (2006) Effectiveness of interventions for the treatment of acute and prevention of recurrent gout–a systematic review. Rheumatology 45(11), 1422-1431. [Abstract] [Free Full-text]
66. Terkeltaub, R.A. (2003) Gout. New England Journal of Medicine 349(17), 1647-1655.
67. Thompson, G.R., Duff, I.F., Robinson, W.D. et al. (1962) Long term uricosuric therapy in gout. Arthritis & Rheumatism 5(Aug), 384-396.
68. Underwood, M. (2006a) Diagnosis and management of gout. British Medical Journal 332(7553), 1315-1319. [Free Full-text]
69. Underwood, M. (2006b) Gout. Clinical Evidence. BMJ Publishing Group Ltd. www.clinicalevidence.com
70. Wallace, S.L., Robinson, H., Masi, A.T. et al. (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis & Rheumatism 20(3), 895-900. [Abstract]
71. Warrell, D.A., Cox, T.M. and Firth, J.D. (Eds.) (2003a) Oxford textbook of medicine. Volume 3. 4th edn. New York: Oxford University Press.
72. Warrell, D.A., Cox, T.M. and Firth, J.D. (Eds.) (2003b) Oxford textbook of medicine. Volume 2. 4th edn. New York: Oxford University Press.
73. Weinberger, A., Schreiber, M., Sperling, O. and DeVeris, A. (1975) Comparative evaluation of uricosuric and allopurinol treatment in a series of 183 gouty patients. International Reviews in Rheumatology 5, 681-685.
74. Yu, T.F. and Gutman, A.B. (1959) Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. Journal of Clinical Investigation 38(8), 1298-1315. [Free Full-text]
75. Yu, T.F. and Gutman, A.B. (1964) Effect of allopurinol (4-hydroxypyrazolo(3, 4-d)pyrimidine) on serum and urinary uric acid in primary and secondary gout. American Journal of Medicine 37, 885-898.